Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,770 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports.
Petri M, Landy H, Clowse MEB, Gemzoe K, Khamashta M, Kurtinecz M, Levy RA, Liu A, Marino R, Meizlik P, Pimenta JM, Sumner K, Tilson H, Connolly MB, Wurst K, Harris J, Quasny H, Juliao P, Roth DA. Petri M, et al. Among authors: roth da. Ann Rheum Dis. 2022 Oct 5:annrheumdis-2022-222505. doi: 10.1136/ard-2022-222505. Online ahead of print. Ann Rheum Dis. 2022. PMID: 36198440
MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS.
DeZern A, Fenaux P, Deeren D, Campelo MD, Lübbert M, Krishnamurthy P, Nagy Z, Basak G, Ová AJ, Geissler K, Ofran Y, Volkert A, Baker K, Chisholm J, Kang-Fortner Q, Roth DA, Kelly M, Marconi G. DeZern A, et al. Among authors: roth da. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S303-S304. doi: 10.1016/S2152-2650(22)01395-7. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36163942 Clinical Trial.
AML-108 SELECT-AML-1 Trial in Progress: A Phase 2 Study of Tamibarotene in Combination With Venetoclax and Azacitidine in Previously Untreated Adult Patients Selected for RARA-Positive AML who are Ineligible for Standard Induction Therapy.
Kambhampati S, Eghtedar A, McMahon C, de Botton S, Pigneux A, Ball B, Borthakur G, Volkert A, Gausman JA, Baker K, Hodgson G, Warlick E, Roth D, Kelly M, Pollyea D, Stein E. Kambhampati S, et al. Among authors: roth d. Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S213. doi: 10.1016/S2152-2650(22)01221-6. Clin Lymphoma Myeloma Leuk. 2022. PMID: 36163766 Clinical Trial.
Efficacy and Safety of Belimumab in Patients With Lupus Nephritis: Subgroup Analyses of a Phase 3 Randomized Trial in the East Asian Population.
Yu X, Chen N, Xue J, Mok CC, Bae SC, Peng X, Chen W, Ren H, Li X, Noppakun K, Gilbride JA, Green Y, Ji B, Liu C, Madan A, Okily M, Tang CH, Roth DA. Yu X, et al. Among authors: roth da. Am J Kidney Dis. 2022 Sep 1:S0272-6386(22)00860-5. doi: 10.1053/j.ajkd.2022.06.013. Online ahead of print. Am J Kidney Dis. 2022. PMID: 36058429
1,770 results